FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

Source: FDA Center for Drug Evaluation and Research - What's New - February 14, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news